| Schedule of Basic and Diluted Earnings per Share |
The following table provides the numerators and denominators used in computing basic and diluted net income (loss) per share for the three months ended September 30, 2024 and 2023: | | | | | | | | | | | | | For the Three Months Ended September 30, | | 2024 | | 2023 | Net (loss) income for basic earnings per share | $ | (384,133) | | | $ | 14,932 | | Effect of potentially dilutive shares: | | | | | Adjustment for interest on Convertible Notes | — | | | 4,449 | | Adjustment for fair value gains on embedded derivatives for Convertible Notes | — | | | (27,398) | | Net loss for diluted earnings per share | $ | (384,133) | | | $ | (8,017) | | | | | | Weighted-average basic common shares outstanding | 216,898,374 | | | 138,005,222 | | Dilutive effect of Convertible Notes | — | | | 14,836,450 | | Dilutive effect of April and May Warrants | — | | | 1,344,677 | | Dilutive effect of Restricted Stock Units | — | | | 1,142,184 | | Dilutive effect of Stock Options | — | | | 996,751 | | Weighted-average dilutive common shares outstanding | 216,898,374 | | | 156,325,284 | |
| | | | | | | | | | | | | Earnings per share: | | | | Basic | $ | (1.77) | | | $ | 0.11 | | Diluted | $ | (1.77) | | | $ | (0.05) | |
|
| Schedule of Anti-Dilutive Shares Excluded From Diluted Net Loss Per Share |
For the three months ended September 30, 2023, the following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive. | | | | | | | | | | | Three Months Ended September 30, 2023 | | Public and private placement warrants | | 7,326,654 | | Stock options | | 1,585,056 | |
The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the three months ended September 30, 2024, as well as the nine months ended September 30, 2024 and 2023: | | | | | | | | | | | | | Three and Nine Months Ended September 30, | | Nine Months Ended September 30, | | 2024 | | 2023 | Stock options, RSUs, PRSUs | 26,966,240 | | | 9,239,612 | | | Public and private placement warrants | 104,397,933 | | | 26,928,634 | | Convertible Notes (if converted) | 17,782,644 | | | 14,836,450 | | Series B Preferred Stock | 60,746,526 | | | — | |
|